Related Experiment Video
Updated: Apr 25, 2026

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins
Gaosi Xu1, Weiping Tu, Shulan Qin
1Nanchang University, Nanchang, China. gaosixu@163.com.
Background:
It is unclear to what extent uremic toxins participate in inflammatory responses and the activities of deiodinases, as well as the effects of deiodinases on inflammatory cytokines.
Materials And Methods:
Hepatocellular carcinoma cell lines (HepG2) were transfected with small interfering ribonucleic acid (siRNA) specific for deiodinase type 1 (DIO1) and cultured with or without uremic toxins. The mRNA expression of DIO1, interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α was detected by quantitative real-time PCR. The presence of selenoprotein M (SelM) and DIO1 was assessed by western blotting. Sonicate deiodinase activities in HepG2 cells were measured by a dithiothreitol-stimulated assay. The NF-κB, AP-1 and CREB-1 inflammatory signal pathways were confirmed by EMSA.
Results:
After culturing for 24 h, the mRNA expression of DIO1 was significantly decreased by the specific siRNA (reduced by 76%, P = 0.0002). Uremic toxins significantly increased the mRNA expression (P < 0.01) of IL-1β, IL-6 and TNF-α and inhibited DIO1 mRNA expression (P < 0.01) compared with controls. Suppression of DIO1 by siRNA significantly decreased the mRNA expression of IL-1β and IL-6 (P < 0.05) but not TNF-α (P = 0.093). Uremic toxins and specific siRNA synchronously reduced the protein expression of SelM and DIO1.
Conclusions:
Uremic toxins activate the expression of inflammatory cytokines. The major findings of this study indicate that the uremic toxins, more than inflammatory cytokines, play direct inhibitory roles in DIO1 enzyme activity, which then provides a negative feedback to the growing accumulation of inflammatory cytokines.
Insights
Uremic toxins promote inflammation and inhibit deiodinase type 1 (DIO1) activity. This inhibition creates a feedback loop, increasing inflammatory cytokines in conditions like liver cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Hepatology
Background:
- Uremic toxins are implicated in inflammation, but their precise role alongside deiodinases and inflammatory cytokines remains unclear.
- The interplay between deiodinases, such as deiodinase type 1 (DIO1), and inflammatory processes requires further elucidation.
Purpose of the Study:
- To investigate the impact of uremic toxins on deiodinase type 1 (DIO1) expression and activity.
- To examine the relationship between uremic toxins, DIO1, and the expression of key inflammatory cytokines (IL-1β, IL-6, TNF-α).
Main Methods:
- Hepatocellular carcinoma (HepG2) cells were treated with siRNA targeting DIO1 and exposed to uremic toxins.
- Quantitative real-time PCR and western blotting were used to measure mRNA and protein expression of DIO1, selenoprotein M (SelM), and inflammatory cytokines.
- Enzyme activity assays and electrophoretic mobility shift assays (EMSA) assessed DIO1 activity and inflammatory signaling pathways (NF-κB, AP-1, CREB-1).
Main Results:
- siRNA significantly reduced DIO1 mRNA expression by 76%.
- Uremic toxins increased IL-1β, IL-6, and TNF-α mRNA expression while decreasing DIO1 mRNA expression.
- DIO1 suppression by siRNA reduced IL-1β and IL-6 mRNA but not TNF-α. Both uremic toxins and siRNA decreased SelM and DIO1 protein levels.
Conclusions:
- Uremic toxins directly inhibit DIO1 enzyme activity, contributing to the accumulation of inflammatory cytokines.
- This study reveals a negative feedback mechanism where uremic toxins exacerbate inflammation by suppressing DIO1, impacting liver cancer cell lines.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Chronic Kidney Disease II: Clinical Manifestations
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Stringent Response in E. coli
Inflammatory Bowel Disease III: Crohn's Disease
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
